Cox Aaron

CIK 00019243511 companyDUBLIN, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001924351

Recent Transactions

29 trades

Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,749→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−14,282→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−27,942→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−12,226→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−15,870→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−556→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,749→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−23,806→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,761→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,654→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−11,499→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−22,997→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−9,314→ 0 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-13$113.17/sh−36,148→ 277 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2023-01-04+22,997→ 22,997 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-30+64,906→ 65,183 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−17,416→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−1,573→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−5,806→ 0 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-30$113.80/sh−28,758→ 36,425 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−9,314→ 9,314 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−7,935→ 15,870 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−9,676→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−9,318→ 4,654 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−3,868→ 0 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+17,416→ 17,416 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+13,972→ 13,972 total
Gift
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-15−4,774→ 277 total
Award
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-06-01+277→ 5,051 total

Companies

Horizon Therapeutics Public Ltd Co
EVP, Chief Financial Officer

Recent Filings

Address

C/O HORIZON THERAPEUTICS PLC 70 ST. STEPHEN'S GREEN

DUBLIN, L2

View on SEC.gov